Lv41
490 积分 2024-11-11 加入
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia
1小时前
求助中
Poly(ADP-ribose) polymerase inhibition: past, present and future
1个月前
已完结
The VITAL Trial: Phase II Trial of Vosaroxin and Infusional Cytarabine for Frontline Treatment of acute Myeloid Leukemia
2个月前
已关闭
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study
2个月前
已完结
A New CDK9 Inhibitor on the Block to Treat Hematologic Malignancies
2个月前
已完结
Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies
2个月前
已完结
Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo
2个月前
已完结
A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure
2个月前
已完结
Acute myeloid leukaemia
2个月前
已完结
Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo
2个月前
已关闭
皖公网安备34019202002308
